A share price of Centessa Pharmaceuticals plc ADR [CNTA] is currently trading at $12.77, down -0.78%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The CNTA shares have gain 4.16% over the last week, with a monthly amount drifted -7.40%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Centessa Pharmaceuticals plc ADR [NASDAQ: CNTA] stock has seen the most recent analyst activity on May 08, 2025, when Chardan Capital Markets initiated its Buy rating and assigned the stock a price target of $30. Previously, Piper Sandler started tracking the stock with Overweight rating on March 31, 2025, and set its price target to $38. On January 07, 2025, TD Cowen initiated with a Buy rating. Morgan Stanley upgraded its rating to a Overweight and increased its price target to $26 on September 20, 2024. B. Riley Securities initiated its recommendation with a Buy and recommended $33 as its price target on September 19, 2024. Oppenheimer started tracking with a Outperform rating for this stock on July 18, 2024, and assigned it a price target of $14. In a note dated November 15, 2023, Jefferies upgraded an Buy rating on this stock and boosted its target price from $4 to $11.
Centessa Pharmaceuticals plc ADR experienced fluctuations in its stock price throughout the past year between $7.75 and $19.09. Currently, Wall Street analysts expect the stock to reach $21 within the next 12 months. Centessa Pharmaceuticals plc ADR [NASDAQ: CNTA] shares were valued at $12.77 at the most recent close of the market. An investor can expect a potential return of 64.45% based on the average CNTA price forecast.
Analyzing the CNTA fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.42, Equity is -0.57 and Total Capital is -0.39. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.02.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 12.52 points at the first support level, and at 12.27 for the second support level. However, for the 1st resistance point, the stock is sitting at 13.11, and for the 2nd resistance point, it is at 13.45.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Centessa Pharmaceuticals plc ADR [NASDAQ:CNTA] is 14.37. Further, the Quick Ratio stands at 14.37, while the Cash Ratio is 4.34. Considering the valuation of this stock, the price to sales ratio is 113.25, the price to book ratio is 4.42.
Transactions by insiders
Recent insider trading involved Weinhoff Gregory M, Chief Business Officer, that happened on May 27 ’25 when 10000.0 shares were sold. Officer, Weinhoff Gregory M completed a deal on May 27 ’25 to buy 10000.0 shares. Meanwhile, Chief Executive Officer SAHA SAURABH sold 55000.0 shares on May 20 ’25.
